GLP-1 receptors are expressed in multiple brain regions, including areas involved in arousal, sleep-wake regulation, and energy homeostasis
The most common side effects caused by semaglutide-containing medications include: People metabolize medications differently, so theres no way to predict side effects
Unlike other current weight loss medications on the market, it simultaneously activates three key hormone receptors: GLP-1 receptor GIP receptor Glucagon receptor By targeting all three, Retatrutide delivers a comprehensive approach to weight management by: Suppressing appetite and slowing digestion Enhancing metabolic activity Regulating blood sugar levels Promoting fat breakdown In comparison to other weight loss drugs like Wegovy and Ozempic ( Semaglutide ) that only target GLP-1, while other options like Zepbound and Mounjaro ( Tirzepatide ) activate both GLP-1 and GIP
Antico 2012)
They work by mimicking a natural hormone that helps regulate blood sugar levels, slows stomach emptying, and promotes feelings of fullness
As a result, the medication addresses several key factors in weight management simultaneously